Abstract:Opioids are highly effective analgesics, however, their therapeutic use is limited by adverse effects that include respiratory depression, dependence, and tolerance. Inflammation has been implicated as a significant driver for the development of tolerance to opioids. Recent studies show that chronic morphine in mice results in gut microbial dysbiosis and inflammation in the colon. In the present study, we examined whether colonic inflammation results in tolerance to the antinociceptive effects of morphine. Colonic inflammation was induced in mice by intrarectal administration of 2,4,6-trinitro-benzene sulfonic acid. The development of antinociceptive tolerance was determined by warm-water tail-immersion assay in mice implanted with 25-, 50-, or 75-mg morphine pellet. Colonic inflammation significantly enhanced the rate at which tolerance developed in each cohort of chronic morphine-treated mice. At the lowest dose of morphine pellet (25 mg), antinociceptive tolerance only developed in the presence of colonic inflammation, whereas in 50- and 75-mg pelleted mice, tolerance developed faster in the inflamed animals than in the noninflamed mice. The enhanced antinociceptive tolerance was attenuated with daily administration of peripheral opioid receptor antagonist, 6 beta-N-heterocyclic-substituted naltrexamine derivative 17-cyclopropyInnethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 beta-[(4'pyridyl) acetamido]nnorphinan (NAP)], irrespective of colonic inflammation. Collectively, these findings show that the rate of tolerance to morphine antinociception is exaggerated in the presence of colonic inflammation, and tolerance is prevented by a peripheral mu-opioid receptor antagonist. These studies suggest a peripheral component to the development of antinociceptive tolerance to opioids. Furthermore, peripherally selective opioid antagonists may be useful adjuncts in opioid-based pain management. SIGNIFICANCE STATEMENT This study supports the notion that inflammation influences the development of antinociceptive tolerance to chronic morphine exposure. We found that, in the presence of colonic inflammation, the rate of development of tolerance to the antinociceptive effects of morphine increased. We also found that treatment with a peripheral opioid receptor antagonist prevented morphine antinociceptive tolerance. Increasing opioid intake during an inflammatory state would result in decreased analgesia and enhanced analgesic tolerance, which puts patients with inflammatory bowel diseases, inflammatory joint diseases, and sickle cell anemia at risk for heavy opioid use.

Immunosuppressive effects of morphine on macrophage polarization and function

Altered Membrane Expression and Function of CD11b Play a Role in the Immunosuppressive Effects of Morphine on Macrophages at the Nanomolar Level

Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles

The Role of Opioid Receptors in Immune System Function

Morphine Suppresses IFN Signaling Pathway and Enhances AIDS Virus Infection

Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection

Morphine Potentiates Lps-Induced Autophagy Initiation but Inhibits Autophagosomal Maturation in Murine Macrophages Through Tlr4 Dependent and Independent Signaling

Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways

Morphine Suppresses T Helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway

Morphine Disrupts Interleukin-23 (Il-23)/Il-17-mediated Pulmonary Mucosal Host Defense Against Streptococcus Pneumoniae Infection.

Morphine Induced Exacerbation of Sepsis is Mediated by Tempering Endotoxin Tolerance Through Modulation of Mir-146A

Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection

Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway

Morphine-induced intestinal microbial dysbiosis drives TLR-dependent IgA targeting of gram-positive bacteria and upregulation of CD11b and TLR2 on a sub-population of IgA+ B cells

Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine Via Peripheral Opioid Receptors

Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infection

The Impact of Morphine on the Characteristics and Function Properties of Human Mesenchymal Stem Cells

Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis

Chronic morphine in the context of HIV infection, induce gut microbiome dysbiosis and lead to persistent GALT inflammation. (MUC4P.843)

The role of macrophage subtypes and exosomes in immunomodulation

Morphine Induces Desensitization of Insulin Receptor Signaling